✕

Download the Practo app for free

Get Rs. 200 HealthCash
Download the app now
✔ Book instant appointments 24x7
✔ Bookmark doctors for quick access
✔ Consult online with a doctor in 60s
✕
Free ₹200 worth HealthCash on app
Use HealthCash to order medicines, health products & much more
Get App

Olima 2.5 MG Tablet

Manufactured byMankind Pharmaceuticals Ltd.
ContainsOlanzapine
CURRENTLY UNAVAILABLE

Description

Olima 2.5 MG Tablet is a potent antipsychotic medicine. It affects certain chemicals in the brain and helps in bringing about a change in thought and perception. It is used to treat a variety of psychological and psychiatric disorders such as schizophrenia and bipolar disorder (manic depression).
QUICK LINKS:
Side effectsConcernsUsageRelated products

How will this medicine affect me?

Consult top doctors online and get an answer now.
Consult now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now

Should you be taking this medicine?

Consult with a Doctor for the best diagnosis.

Looking for a doctor?

Book an appointment with the top doctors near you

Substitutes

List of substitutes for Olima 2.5 MG Tablet

Olanex 2.5 MG Tablet
Strides Shasun Ltd.
Olanzotic 2.5 MG Tablet
Glenmark Pharmaceuticals Ltd.
Olexa 2.5 MG Tablet
Cipla Ltd.
Olimelt 2.5 MG Tablet
Intas Pharmaceuticals Ltd.
Oliza 2.5 MG Tablet
Intas Pharmaceuticals Ltd.

Side effects

Major & minor side effects for Olima 2.5 MG Tablet

Orthostatic Hypotension

Weight gain

Headache

Sleepiness

Increase in body fat and cholesterol

Dizziness

Uncontrolled muscle movements

Chest pain

Dry mouth

Running nose and cough

Loss of libido

Change in personality

Uses of Olima 2.5 MG Tablet

What is it prescribed for?

Schizophrenia

This medicine is used in the treatment of Schizophrenia which is a severe and chronic mental disorder characterized by abnormal social behavior and impaired ability to think clearly.

Bipolar disorder

This medicine is used in the treatment of bipolar disorder which is also known as the manic-depressive illness characterized by unusual mood changes.

Depression

This medicine is used in combination with other medicine for the treatment of depression which is a common and serious medical illness characterized by depressed mood, loss of interest in activities in daily life.
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?

    The amount of time required for this medicine to show its action is not clinically established.

  • How long do the effects of this medicine last?

    The amount of time for which this medicine remains active in the body is not clinically established.

  • Is it safe to consume alcohol while taking this medicine?

    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of serious side effects such as difficulty concentrating, dizziness, confusion, drowsiness, etc. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.

  • Is this a habit forming medicine?

    No habit forming tendencies were reported. However, patients with a history of drug abuse should be monitored closely for misuse.

  • Can this medicine be taken during pregnancy?

    This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

  • Can this medicine be taken while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. If the medicine is used, close monitoring of the infant for any undesired effects is necessary.

Allergy

This medicine is not recommended for use if you are known allergic to olanzapine or any other inactive ingredients present in the formulation.

Glaucoma

This medicine is not recommended for use in patients with a known history of glaucoma due to the increased risk of worsening of the patient's condition.

Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. If the medicine is used, close monitoring of the infant for any undesired effects is necessary.

General warnings

Diabetes

This medicine may alter blood glucose levels in diabetic patients. Close monitoring of blood glucose levels is recommended for such patients. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Muscular Disorders

This medicine may cause muscular disorders in some patients. Any incidence of ticks or uncontrolled muscle movements, fever, dizziness, weakness in muscles, etc. should be reported to the doctor immediately. Replacement with a suitable alternative may be required based on the clinical condition of the patient.

Suicidal thoughts

This medicine should be used with caution due to the increased risk of suicidal thoughts. Close monitoring of the patients for any change in behavior or mood is recommended. Appropriate dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Changes in weight

This medicine is known to cause either weight loss or weight gain. Inform the doctor if you experience any changes in body weight. Close monitoring of body weight is recommended during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Orthostatic hypotension

This medicine should be used with caution due to the increased risk of hypotension. Patients are advised to get up slowly from a sitting or a lying position to avoid a sudden drop in the blood pressure. Any symptoms such as fainting, dizziness, lightheadedness, etc. should be reported to the doctor on priority. Close monitoring of blood pressure may be required in some cases. Appropriate dose adjustments may be necessary based on the clinical condition.

Pediatric use

Monotherapy: Alone use of this medicine is not recommended for use in below 13 years of age due to safety and efficacy that have not been clinically established. Combination therapy: A combination of this medicine is not recommended for use in below 10 years of age due to safety and efficacy have not been clinically established.

Driving or Operating machinery

The use of this medicine may cause drowsiness or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Missed Dose

Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.

Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of serious side effects such as difficulty concentrating, dizziness, confusion, drowsiness, etc. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.

Interaction with Medicine

Acarbose

Amlodipine

Cetirizine

Diazepam

Tramadol

Atropine

Disease interactions

Dementia

This medicine is not recommended for use in patients suffering from dementia-related psychosis due to the increased risk of worsening of the patient's condition as well as death.

Central Nervous System Depression

This medicine is not recommended for use if the patient is in a coma or unconscious state and has severe central nervous system depression. Symptoms like a decreased rate of breathing and decreased heartbeat should be reported immediately.

Neuroleptic Malignant Syndrome (NMS)

This medicine is not recommended for use in patients with a known history of neuroleptic malignant syndrome due to the increased risk of worsening of the patient's condition. If the medicine is used, any unusual symptoms should be reported to the doctor on priority. Replacement with a suitable alternative should be considered based on the clinical condition.

Tardive Dyskinesia

This medicine is not recommended for use in patients with a known history of tardive dyskinesia since it may worsen the patient's condition. This risk is especially higher in elderly patients and female patients. Therapy should be discontinued if symptoms such as uncontrolled movements involving the tongue, mouth, lips, jaws, etc. are experienced. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Seizure disorders

This medicine should be used with caution in patients with a history of seizure disorders since it may worsen the patient's condition. Close monitoring of the patient is necessary during treatment with this medicine. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Diabetes

This medicine should be used with caution in patients with diabetes mellitus due to the increased risk of altered blood glucose levels. Close monitoring of blood sugar levels is recommended for such patients. Replacement with a suitable alternative may be necessary in some cases based on the clinical condition of the patient.

Impaired liver function

This medicine should be used with extreme caution in patients suffering from liver diseases due to the increased risk of serious adverse effects. Close monitoring of liver function tests, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Impaired kidney function

This medicine should be used with caution in patients with a history of kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Food interactions

Information not available.

Lab interactions

Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take this medicine with or without food. Do not take in larger amounts than advised. Consult the doctor if you experience any undesirable effects. Do not stop taking the medicine without consulting your doctor as it may cause withdrawal symptoms.

Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Causes sleepiness

How it works

This medicine works by blocking the excitatory action of certain neurotransmitters, the chemicals which are used by the nerves to communicate with each other in the brain.

Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Atypical antipsychotics

Schedule

Schedule H

olanzapine | C17H20N4S - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 28 February 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/4585

Olanzapine: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 28 February 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a601213.html

Olanzapine - DrugBank [Internet]. Drugbank.ca. 2020 [cited 17 February 2020]. Available from:

https://www.drugbank.ca/drugs/DB00334

[Internet]. Medicines.org.uk. 2020 [cited 17 February 2020]. Available from:

https://www.medicines.org.uk/emc/files/pil.3071.pdf

Related Questions

Something doesn’t feel right?
Report an error

Information on this page was last updated on 5 Mar 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.